General Assembly Meeting Thursday, May 5th 10:00 – 13:00

General Assembly Meeting - 2022

A virtual (Zoom) and face-to-face meeting in Paris, France

followed by Lunch

Other Logistical information to follow nearer the time




The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.


Introduction. A study was performed to assess the effect of the test item on the survival and reproduction of Ceriodaphnia dubia over an 8-Day period. The method followed that described in the OECD Guidelines for Testing of Chemicals No 211 (1998) "Daphnia magna, Reproduction Test", US EPA Short-term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to Freshwater Organisms (Method 1002.0) and OPPTS Ecological Effects Test Guideline, Daphnid Chronic Toxicity Test OPPTS 850.1300.


Results. The 8-Day EC50 (immobilisation) value based on the nominal test concentrations, for the parental Ceriodaphnia generation (P1) was estimated to be greater than 100% v/v saturated solution.


The 8-Day EC50 (reproduction) value based on the nominal test concentrations was calculated to be 32% v/v saturated solution with 95% confidence limits of 20 - 50% v/v saturated solution.


The "Lowest Observed Effect Concentration" was considered to be 32% v/v saturated solution on the basis that at this test concentration produced significantly fewer live young per adult (P<0.05) than the control.


The "No Observed Effect Concentration" was considered to be 10% v/v saturated solution on the basis that at this test concentration there were no significant mortalities (immobilisation) observed in the parental generation (P1) and that there were no significant differences (P≥0.05) between the control and the 10% v/v saturated solution test group in terms of numbers of live young produced per adult by Day 8.


The test item contains a theoretical manganese content of 63% w/w. The test samples were analysed for manganese only. Analysis of the test preparations on Days 0, 2, 5, 7 and 8 showed measured concentrations of manganese to be less than the limit of quantitation (LOQ) of the analytical method (assessed as 0.050 mg manganese/l) with the exception of the 32% and 100% v/v saturated solution on Days 0 (fresh media) and 2 (old media). Analysis of these samples showed measured concentrations as test item of 0.233 and 0.810 on Day 0 and 0.138 and 0.666 mg/l on Day 2.


Given that the majority of the analyses were less than the LOQ, it was considered justifiable to base the results on nominal test concentrations only.


To obtain the full study, please contact:


« Back to studies

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)